Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

Clinical trial NCT03114280 · WITHDRAWN

Trial details

NCT number: NCT03114280
Sponsor: Centre Antoine Lacassagne
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma (HNSCC)

Start date: 2019-03-12
Primary completion: 2019-03-12
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.